BTW, might be time for you to look at
CYP under 50c again.
Think it's time for a turnaround, and expecting a very good 2022 from low base.
Chart looking ripe for reversal. (cant get much worse!)
Lots trials happening. US GvHD FDA/IND will give it a good kick Q1 next year imo and get on more radars.
New wound care trial starting now
ARDs/Covid trial about to finish and get some readout Q1 also
Ongoing Large Phase 3 in OA
Cap around $70m
Cash $30m
Super undervalued EV at under $40m now.
4 trials happening.
My best tip for 2022 at present...but like I mentioned with PSC, I didn't tip it for 4 weeks, as too short for my timeframes these days. another 6-12 month bagger.
Like PSC, AJQ no volume, no interest at present.
